Cargando…

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation

The objectives of this study were to develop a population pharmacokinetic model of prophylactically administered cefazolin in patients undergoing cardiac surgery with and without the use of the cardiopulmonary bypass of both existing types—standard (ECC) and minimallyu invasive extracorporeal circul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Šantavý, Petr, Šíma, Martin, Zuščich, Ondřej, Kubíčková, Vendula, Michaličková, Danica, Slanař, Ondřej, Urbánek, Karel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686470/ https://www.ncbi.nlm.nih.gov/pubmed/36358235 http://dx.doi.org/10.3390/antibiotics11111582

Ejemplares similares

What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
por: Šíma, Martin, et al.
Publicado: (2021)

Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: protocol for the COL-ECMO2022 trial – a prospective, non-randomised, open-label phase IV pharmacokinetic clinical trial
por: Suk, Pavel, et al.
Publicado: (2023)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
por: Šíma, Martin, et al.
Publicado: (2021)

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications
por: Hartinger, Jan Miroslav, et al.
Publicado: (2023)

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice
por: Michaličková, Danica, et al.
Publicado: (2020)

Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs
por: Královičová, Jana, et al.
Publicado: (2022)

Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review
por: Rychlíčková, Jitka, et al.
Publicado: (2023)

Dose Optimization and Targeting Strategies of Anti-Infective Agents
por: Šíma, Martin, et al.
Publicado: (2023)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Cefazolin Pharmacokinetics in Premature Infants
por: Balevic, Stephen J., et al.
Publicado: (2019)

Prophylactic Cefazolin Dosing in Obesity—a Systematic Review
por: Coates, Matthew, et al.
Publicado: (2022)

Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections
por: Murínová, Irena, et al.
Publicado: (2022)

Prophylactic cefazolin in amnioinfusions administered for meconium-stained amniotic fluid.
por: Edwards, R K, et al.
Publicado: (1999)

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
por: Dvořáčková, Eliška, et al.
Publicado: (2023)

Population pharmacokinetic model of cefazolin in total hip arthroplasty
por: Lanoiselée, J., et al.
Publicado: (2021)

Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin
por: Šíma, Martin, et al.
Publicado: (2022)

CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
por: Kobayashi, Shunsuke, et al.
Publicado: (2022)

Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives
por: Hartinger, Jan Miroslav, et al.
Publicado: (2022)

Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy
por: van Hasselt, J. G. Coen, et al.
Publicado: (2014)

Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients
por: Novak, Alison R, et al.
Publicado: (2021)

Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients?
por: Hussain, Zahid, et al.
Publicado: (2018)

Corrigendum to “Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy”
por: van Hasselt, J. G. Coen, et al.
Publicado: (2015)

Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients
por: Schmitz, Michael L., et al.
Publicado: (2020)

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery
por: Alli, Ahmad, et al.
Publicado: (2023)

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
por: Sobels, Annemieke, et al.
Publicado: (2022)

From less invasive to minimal invasive extracorporeal circulation
por: Anastasiadis, Kyriakos, et al.
Publicado: (2021)

Expression of Biliverdin Reductase A in Peripheral Blood Leukocytes Is Associated with Treatment Response in HCV-Infected Patients
por: Subhanova, Iva, et al.
Publicado: (2013)

Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses
por: Kuroda, Taisuke, et al.
Publicado: (2021)

A Novel Minimal Invasive Mouse Model of Extracorporeal Circulation
por: Luo, Shuhua, et al.
Publicado: (2015)

Toward Minimally Invasive Extracorporeal Circulation in Oncologic Cardiac Surgery
por: Condello, Ignazio, et al.
Publicado: (2021)

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
por: Hofmann, Jiří, et al.
Publicado: (2023)

Is it just a cefazolin issue?
por: Takazawa, Tomonori, et al.
Publicado: (2019)

Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures
por: Depcinski, Shawn C., et al.
Publicado: (2019)

Minimal invasive extracorporeal circulation an alternative to ECMO in ventricular tachycardia ablation
por: Condello, Ignazio
Publicado: (2023)

lncRNA PVT1 in the Pathogenesis and Clinical Management of Renal Cell Carcinoma
por: Bohosova, Julia, et al.
Publicado: (2021)

The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery
por: Douglas, Alexandra, et al.
Publicado: (2011)

Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI)
por: So, Wonhee, et al.
Publicado: (2014)

Prevention of Surgical Site Infections and Biofilms: Pharmacokinetics of Subcutaneous Cefazolin and Metronidazole in a Tumescent Lidocaine Solution
por: Klein, Jeffrey A., et al.
Publicado: (2017)

Comparison the Efficacy of Cefazolin plus Gentamicin with Cefazolin plus Ciprofloxacin in Management of Type –IIIA Open Fractures
por: Janmohammadi, N, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jgeedtnrglhnmgn9l0egaubv7e